We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Eduardo Solessio is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2009 |
Solessio, Eduardo |
R56Activity Code Description: To provide limited interim research support based on the merit of a pending R01 application while applicant gathers additional data to revise a new or competing renewal application. This grant will underwrite highly meritorious applications that if given the opportunity to revise their application could meet IC recommended standards and would be missed opportunities if not funded. Interim funded ends when the applicant succeeds in obtaining an R01 or other competing award built on the R56 grant. These awards are not renewable. |
Metabolic Modulation of Vision @ Upstate Medical University
Specific Aims Broadly, there are two major specific aims for the coming project period. One is the identification of the excitatory molecule for the TRP/TRPL channels and the other is the detailed analysis of three mutants that remain uncharacterized. a. Search for the excitatory molecule for TRP/TRPL channels. This project is a direct continuation of the inaE project completed in the previous project period and represents an attempt to finally close the chapter on the long-standing search for arguably the most sought-after molecule in the field. There will be two basic strategies: i) to identify the excitatory molecule by exogenous application of candidate molecules in whole-cell recordings, and ii) to attempt to obtain genetic evidence as to whether or not monoacylglycerol lipase (MAGL) is involved in the channel activation process by identifying the MAGL gene involved and isolating mutations in the gene. The third part of this aim is to explore whether or not diacylglycerol (DAG) has a synergistic enhancing role in channel excitation even though it has no direct excitatory role itself. b. Analysis of three mutants selected from those that remain uncharacterized. Two of these, P226 and ninaF, were chosen in part because we have made striking progress in the preliminary identification of the genes harboring the lesions responsible for the phenotypes. The third mutant, US2985, was chosen solely on the basis of its interesting phenotype. In the case of P226, we will explore the preliminary hypothesis that its dark adaptation-dependent PDA phenotype is related to metarhodopsin deactivation by extensive, multiple phosphorylation. Because the P226 gene has been tentatively identified to be an ortholog of Usher syndrome genes, the project may shed light on the mechanism of retinal degeneration in Usher syndrome. In the ninaF project, we will explore the hypothesis that the protein encoded by this gene performs a function related to those of NINAC myosin III. In the US2985 project, we will explore the hypothesis that this mutant is impaired in Ca2+-mediated adaptation, but not in Ca2+-mediated activation of response. The project has the potential for identifying a protein specifically involved in Ca2+-mediated adaptation.
|
1 |
2016 — 2020 |
Solessio, Eduardo C |
R01Activity Code Description: To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
Contribution of Rod Photoresponse Inactivation Kinetics to Visual Temporal Contrast Sensitivity in Mesopic Light @ Upstate Medical University
? DESCRIPTION (provided by applicant): The human visual system has a remarkable capacity to detect differences in contrast (i.e., differences in luminance across space or time) as small as 1:500. This ability underlies the performance of everyday visual tasks such as reading, driving, and face recognition. Indeed, deficits in contrast sensitivity are used as diagnostic signs for the assessment of retinal disease. Despite its importance, the underlying cellular and network mechanisms that encode and limit contrast sensitivity remain elusive. Past work has assigned the photoreceptor frequency response as one mechanism that limits temporal contrast sensitivity (TCS); however, this has not been demonstrated empirically. The goal of this proposal is to determine how rod photoresponse kinetics contributes to visual TCS in mesopic conditions, when rod photoreceptors integrate the response of multiple photoisomerizations. The underlying hypothesis is that rod inactivation kinetics constrains TCS by limiting the speed of the responses of rods to light decrements. To test the hypothesis, a novel operant behavioral assay was developed which establishes in mouse a model of human temporal vision that matches fundamental properties of human visual psychophysics. In the operant assay, mice are trained to detect and respond to a flickering visual stimulus, an action that requires cortical inpt and decision-making. The preliminary data collected with the operant behavior assay suggest that transgenic mice with fast rod inactivation kinetics have higher temporal contrast sensitivity than control mice. Combined with standard electrophysiological tools and transgenic models, the behavioral assay allows dissection of the contributions of rod kinetics to vision. Aim 1 test how rods respond to dynamic stimuli and what impact adaptation mechanisms have on the sensitivity to different frequencies of stimulation in mesopic light levels. Aim 2 tests the contribution of rod photoresponses kinetics to visual (behavioral) contrast sensitivity. Aim 3 test retinal and visual temporal contrast sensitivity in a rhodopsin P23H mouse model of retinitis pigmentosa to test the hypothesis that mutant mice harboring this mutation will exhibit higher TCS than control mice. We predict this because patients and mouse models harboring the P23H rhodopsin mutation exhibit faster rod recovery responses than control subjects. Results of this aim may well provide proof-of-principle for an early and practical visual function test that i diagnostic of certain forms of autosomal dominant retinitis pigmentosa. This project will be significant because it will help understand 1) the contributions of rod kinetics to visual TCS in normal and diseased retinas, and 2) provide insights into the dynamic retinal interactions between rod and cone signals that determine the temporal, spatial, and spectral sensitivities of mesopic vision. The proposed research is innovative, because it examines visual properties common to mouse and humans using a novel operant behavioral assay developed by our research group.
|
0.958 |